Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
arose, attrition, consummated, disadvantage, dissolving, district, entirety, expedient, FASBASU, Indonesia, issuedASU, iv, judge, Lloyd, Mackenzie, Malaysia, morale, nonrefundable, ofASU, outplacement, Pharma, pursuit, ratio, reallocation, retention, South, Taiwan, thirteen, unconstitutional, unintended, unproductive, unvested, workforce
Removed:
absorption, abundance, activate, activated, activating, activation, activator, agent, Alam, Allergan, allergic, alternate, analgesic, anesthetic, annum, API, apportioned, assay, basal, bicarbonate, biodistribution, bioequivalence, biologic, block, bone, book, botugel, bowel, brand, breached, building, capability, capture, catheter, cell, cellular, CMO, companion, composition, concentrate, concentrating, confirmed, considerable, constantly, Cooperation, cure, database, David, debilitating, defray, degradation, delta, deployed, diagnosed, diarrhea, diary, diet, Dimethylsulfoxide, directed, discontinued, discount, DMSO, dose, dosing, earliest, electronic, element, Elmiron, emotional, employ, endeavor, environment, enzyme, erosion, excessive, excreted, expansion, explore, exposing, expressed, fasting, feasibility, fibrotic, flexibility, focusing, forfeiture, frequently, function, gamma, gap, gastric, gastrointestinal, generation, globally, grow, growing, headcount, heparin, homolog, immune, importance, improving, inconvenient, innovation, instillation, Institute, intention, intentionally, interior, intermittent, internationally, intimate, intravesical, invalidated, invasive, irritate, irritation, issuing, Janssen, Kamran, kidney, kinase, knockout, largely, leisure, length, lidocaine, line, lining, linked, linking, male, marrow, men, messenger, metabolized, Mexico, migrate, migration, minimizing, modulation, motivating, mouse, multiple, muscle, nausea, negotiated, nerve, neurogenic, noncurrent, Norway, noted, NRS, numeric, observed, ocular, oncology, opportunistic, optimize, orally, overactive, oversee, parent, partner, partnering, path, pathway, PCT, pelvic, pentosan, perspective, Pfizer, pharmacokinetic, phosphatase, plasma, polysulfate, Poverty, PPS, progressively, projected, proliferation, prompt, prostate, protein, PTA, PTE, PTEN, radiating, rapid, rating, reducing, regulator, reinterpreted, relaxant, release, relevance, reproducible, restore, retroactive, Russia, scalable, screen, selective, selectivity, sensitivity, separately, sexually, signaling, sodium, span, specialist, specificity, sponsored, stimulated, strategically, substance, suggest, suggested, supporting, supportive, suppressed, survival, symptom, synthetic, tanezumab, targeting, temporarily, tensin, therapy, throughput, tissue, tolerated, toxicology, tract, transferred, transmitted, treating, Treaty, underlying, undertaken, underway, unmet, unproven, unsuccessful, unsuitable, unusual, upset, urgency, Urigen, urinary, urine, urological, utilize, utilizing, validated, Vice, vitro, women, worsening, Zealand
Filing tables
Filing exhibits
NGNE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration StatementsNos.333-194490,333-203179,333-210172,333-216572 and333-223589 on FormS-8 and Nos.333-203180,333-208651,333-215457 and333-223584 on FormS-3 of our report dated March 7, 2019, relating to the consolidated financial statements of Aquinox Pharmaceuticals, Inc. and subsidiary appearing in this Annual Report on Form10-K of Aquinox Pharmaceuticals, Inc. for the year ended December 31, 2018.
/s/ Deloitte LLP
Chartered Professional Accountants
Vancouver, Canada
March 7, 2019